ONCAlert | Upfront Therapy for mRCC
News
TMB Shows Promise as Biomarker for Durvalumab Activity in NSCLC
6:19 PM, Fri April 19, 2019
FDA Grants Fast Track and Orphan Drug Designations to Novel Agent Targeting P53 in MDS
2:08 PM, Fri April 19, 2019
Levy Works Through Therapy Options in Patients With NSCLC Who Lack a Driver Mutation
6:27 PM, Thu April 18, 2019
Real-Life Experiences Demonstrate Benefit of Sorafenib-Regorafenib Sequential Therapy in Advanced HCC
2:03 PM, Thu April 18, 2019
Study Solidifies Confidence in Liquid Biopsies for Faster Biomarker Detection in NSCLC, Expert Says
5:50 PM, Wed April 17, 2019
Bevacizumab/Erlotinib Combination Provides Another Frontline Option in EGFR+ NSCLC
4:48 PM, Wed April 17, 2019
Standard Therapy Selection for Cholangiocarcinoma Needs Further Interpretation
3:19 PM, Wed April 17, 2019
